Business Description
Cleo Diagnostics Ltd
ISIN : AU0000288045
Description
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.32 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -0.43 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.94 | |||||
| 9-Day RSI | 43.4 | |||||
| 14-Day RSI | 46.65 | |||||
| 6-1 Month Momentum % | -2.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 51.61 | |||||
| Quick Ratio | 51.61 | |||||
| Cash Ratio | 50.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -126.88 | |||||
| ROA % | -89.66 | |||||
| ROIC % | -268.43 | |||||
| ROC (Joel Greenblatt) % | -14569.23 | |||||
| ROCE % | -122.64 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.26 | |||||
| Price-to-Tangible-Book | 2.31 | |||||
| EV-to-EBIT | -6.63 | |||||
| EV-to-EBITDA | -6.74 | |||||
| EV-to-FCF | -14.21 | |||||
| Price-to-Net-Current-Asset-Value | 2.31 | |||||
| Price-to-Net-Cash | 2.31 | |||||
| Earnings Yield (Greenblatt) % | -15.08 | |||||
| FCF Yield % | -7.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cleo Diagnostics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.049 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 46.65 | ||
| 14-Day ATR (A$) | 0.006604 | ||
| 20-Day SMA (A$) | 0.1905 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (A$) | 0.14 - 0.23 | ||
| Shares Outstanding (Mil) | 128.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cleo Diagnostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cleo Diagnostics Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cleo Diagnostics Ltd Frequently Asked Questions
What is Cleo Diagnostics Ltd(ASX:COV)'s stock price today?
The current price of ASX:COV is A$0.19. The 52 week high of ASX:COV is A$0.23 and 52 week low is A$0.14.
When is next earnings date of Cleo Diagnostics Ltd(ASX:COV)?
The next earnings date of Cleo Diagnostics Ltd(ASX:COV) is .
Does Cleo Diagnostics Ltd(ASX:COV) pay dividends? If so, how much?
Cleo Diagnostics Ltd(ASX:COV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers